China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)

SHA:600062 Revenue

China Resources Double-Crane Pharmaceutical had revenue of 2.81B CNY in the quarter ending March 31, 2026, a decrease of -8.84%. This brings the company's revenue in the last twelve months to 10.73B, down -3.74% year-over-year. In the year 2025, China Resources Double-Crane Pharmaceutical had annual revenue of 11.00B, down -1.88%.

• Revenue (ttm): 10.73B
• Revenue Growth: -3.74%
• P/S Ratio: 1.57
• Revenue / Employee: 813.76K
• Employees: 13,184
• Market Cap: 16.90B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	11.00B	-210.83M	-1.88%
Dec 31, 2024	11.21B	-98.52M	-0.87%
Dec 31, 2023	11.31B	1.68B	17.50%
Dec 31, 2022	9.63B	513.80M	5.64%
Dec 31, 2021	9.11B	607.58M	7.14%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 6, 2026

Data Sources Report a data error